RonaldEdwardPruittMD

PubMed

• Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo...
  Papp KA, Langley RG, Lebwohl M, Krueger GG, Szapary P, Yeilding N, Guzzo C, Hsu MC, Wang Y, Li S, Dooley LT, Reich K, PHOENIX 2 study investigators> ;Lancet (London, England).
• Evaluation of recombinant platelet-activating factor acetylhydrolase for reducing the incidence and severity of post-ERCP acute pancreatitis.
  Sherman S, Alazmi WM, Lehman GA, Geenen JE, Chuttani R, Kozarek RA, Welch WD, Souza S, Pribble J, rPAF-AH ERCP Study Group> ;Gastrointestinal endoscopy.
• 3 citations
  Muscarinic receptor antagonist activity of diacylglycerol lipase and kinase inhibitors.
  M C Sekar, K. E. J. Dickinson, R. E. Pruitt, B. I. Hirschowitz, L. E. Hokin> ;Biochemical Pharmacology. 1990 Jun 15
• 124 citations
  A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy.
  Douglas K. Rex, Raj Bhandari, Taddese Desta, Michael P. DeMicco, Cynthia Schaeffer, K.P. Etzkorn, Charles F. Barish, Ronald E. Pruitt, Brooks D. Cash, D. Quirk, Felix ...> ;Gastrointestinal Endoscopy. 2018 Sep 1
• Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.
  Nissen SE, Yeomans ND, Solomon DH, Lüscher TF, Libby P, Husni ME, Graham DY, Borer JS, Wisniewski LM, Wolski KE, Wang Q, Menon V, Ruschitzka F, Gaffney M, Beckerman B,...> ;The New England journal of medicine. 2016-11-13
• 27 citations
  Effects of preceding endoscopic mucosal resection on the efficacy and safety of radiofrequency ablation for treatment of Barrett’s esophagus: results from the United S...
  Nan Li, Sarina Pasricha, William J. Bulsiewicz, Ronald Pruitt, Srinadh Komanduri, Herbert C. Wolfsen, Gary W. Chmielewski, F. S. Corbett, Kenneth J. Chang, Nicholas J....> ;Diseases of the Esophagus. 2016 Aug 1
• 7 citations
  Once-daily mesalamine granules for maintaining remission of ulcerative colitis: pooled analysis of efficacy, safety, and prognostic factors
  Salam Zakko, Glenn L. Gordon, Uma K. Murthy, Shahriar Sedghi, Ronald E. Pruitt, Andrew C. Barrett, Enoch Bortey, Craig Paterson, William P. Forbes, Gary R. Lichtenstein> ;Postgraduate Medicine. 2016 Mar 1
• 51 citations
  AVX-470, an Orally Delivered Anti-Tumour Necrosis Factor Antibody for Treatment of Active Ulcerative Colitis: Results of a First-in-Human Trial.
  M. Scott Harris, Deborah Hartman, Brenda Lemos, Emma C. Erlich, Sharon Spence, Sally Kennedy, Theadore Ptak, Ronald Pruitt, Severine Vermeire, Barbara S. Fox> ;Journal of Crohn's & Colitis. 2016 Jun 1
• 4 citations
  Long-Term Benefit of Mesalamine Granules for Patients Who Achieved Corticosteroid-Induced Ulcerative Colitis Remission.
  Gary R. Lichtenstein, Glenn L. Gordon, Salam Zakko, Uma K. Murthy, Shahriar Sedghi, Ron E. Pruitt, Andrew C. Barrett, Enoch Bortey, Craig Paterson, William P. Forbes> ;Digestive Diseases and Sciences. 2016 Jan 1
• Daclatasvir plus Simeprevir with or Without Ribavirin for the Treatment of Chronic Hepatitis C Virus Genotype 1 Infection
  Stephanie Noviello, Ronald Pruitt> ;Elsevier.
• 17 citations
  Once-daily Mesalamine Formulation for Maintenance of Remission in Ulcerative Colitis: A Randomized, Placebo-controlled Clinical Trial.
  Glenn L. Gordon, Salam Zakko, Uma K. Murthy, Shahriar Sedghi, Ronald E. Pruitt, Andrew C. Barrett, Enoch Bortey, Craig Paterson, William P. Forbes, Gary R. Lichtenstein> ;Journal of Clinical Gastroenterology. 2015 Sep 1
• 60 citations
  Incidence of Esophageal Adenocarcinoma and Causes of Mortality After Radiofrequency Ablation of Barrett’s Esophagus
  W. Asher Wolf, Sarina Pasricha, Cary C. Cotton, Nan Li, George Triadafilopoulos, V. Raman Muthusamy, Gary W. Chmielewski, F. Scott Corbett, Daniel S. Camara, Charles J...> ;Gastroenterology. 2015 Dec 1
• 32 citations
  Effects of the Learning Curve on Efficacy of Radiofrequency Ablation for Barrett's Esophagus
  Sarina Pasricha, Cary C. Cotton, Kelly Hathorn, Nan Li, William J. Bulsiewicz, W. Asher Wolf, V. Raman Muthusamy, Srinadh Komanduri, Herbert C. Wolfsen, Ron E. Pruitt,...> ;Gastroenterology. 2015 Oct 1
• Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ...
  Cannon CP, Cariou B, Blom D, McKenney JM, Lorenzato C, Pordy R, Chaudhari U, Colhoun HM, ODYSSEY COMBO II Investigators> ;European heart journal. 2015-02-16
• 222 citations
  A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s Disease
  William J. Sandborn, Subrata Ghosh, Julián Panés, Ivana Vranic, Wenjin Wang, Wojciech Niezychowski, Severine Vermeire, Olivier Dewit, Harald Peeters, Jiri Stehlik, Tom...> ;Clinical Gastroenterology and Hepatology. 2014 Sep 1
• Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection.
  Afdhal N, Reddy KR, Nelson DR, Lawitz E, Gordon SC, Schiff E, Nahass R, Ghalib R, Gitlin N, Herring R, Lalezari J, Younes ZH, Pockros PJ, Di Bisceglie AM, Arora S, Sub...> ;The New England journal of medicine. 2014-04-11
• Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.
  Afdhal N, Zeuzem S, Kwo P, Chojkier M, Gitlin N, Puoti M, Romero-Gomez M, Zarski JP, Agarwal K, Buggisch P, Foster GR, Bräu N, Buti M, Jacobson IM, Subramanian GM, Din...> ;The New England journal of medicine. 2014-04-11
• Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis.
  Kowdley KV, Gordon SC, Reddy KR, Rossaro L, Bernstein DE, Lawitz E, Shiffman ML, Schiff E, Ghalib R, Ryan M, Rustgi V, Chojkier M, Herring R, Di Bisceglie AM, Pockros ...> ;The New England journal of medicine. 2014-04-10
• Germline variants and advanced colorectal adenomas: adenoma prevention with celecoxib trial genome-wide association study.
  Wang J, Carvajal-Carmona LG, Chu JH, Zauber AG, APC Trial Collaborators, Kubo M, Matsuda K, Dunlop M, Houlston RS, Sieber O, Lipton L, Gibbs P, Martin NG, Montgomery G...> ;Clinical cancer research : an official journal of the American Association for Cancer Research. 2013-10-01
• 8 citations
  Mesalazine granules 1.5 g once-daily maintain remission in patients with ulcerative colitis who switch from other 5-ASA formulations: a pooled analysis from two random...
  Gary R. Lichtenstein, Salam Zakko, G. L. Gordon, Uma K. Murthy, S. Sedghi, Ronald E. Pruitt, Kunal Merchant, Enoch Bortey, William P. Forbes> ;Alimentary Pharmacology & Therapeutics. 2012 Jul 1
• 90 citations
  Computer-assisted personalized sedation for upper endoscopy and colonoscopy: a comparative, multicenter randomized study.
  Daniel J. Pambianco, John J. Vargo, Ronald E. Pruitt, Robert Hardi, James F. Martin> ;Gastrointestinal Endoscopy. 2011 Apr 1
• 43 citations
  Clinical trial: once-daily mesalamine granules for maintenance of remission of ulcerative colitis - a 6-month placebo-controlled trial.
  Gary R. Lichtenstein, G. L. Gordon, Salam Zakko, Uma K. Murthy, S. Sedghi, Ronald E. Pruitt, Kunal Merchant, Audrey L. Shaw, Enoch Bortey, William P. Forbes> ;Alimentary Pharmacology & Therapeutics. 2010 Oct 1
• Statin use and colorectal adenoma risk: results from the adenoma prevention with celecoxib trial.
  Bertagnolli MM, Hsu M, Hawk ET, Eagle CJ, Zauber AG, Adenoma Prevention with Celecoxib (APC) Study Investigators> ;Cancer prevention research (Philadelphia, Pa.). 2010-04-19
• Radiofrequency ablation of Barrett''s esophagus: outcomes of 429 patients from a multicenter community practice registry.
  Lyday, W. D., Corbett, F. S., Kuperman, D. A., Kalvaria, I., Mavrelis, P. G., Shughoury, A. B., Pruitt, R. E.> ;Endoscopy. 2010 Apr
• 41 citations
  Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, pl...
  Ellen Scherl, Ronald E. Pruitt, Glenn L. Gordon, Mark Lamet, Audrey L. Shaw, Shirley Huang, Shadreck M. Mareya, William P. Forbes> ;The American Journal of Gastroenterology. 2009 Jun 1
• Join now to see all